Literature DB >> 8800157

Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations.

M C Seghaye1, R G Grabitz, J Duchateau, S Busse, S Däbritz, D Koch, G Alzen, H Hörnchen, B J Messmer, G Von Bernuth.   

Abstract

We studied the inflammatory reaction related to cardiopulmonary bypass in 24 neonates (median age 6 days) undergoing the arterial switch operation for simple transposition of the great arteries, with respect to the development of postoperative capillary leak syndrome. Complement proteins, leukocyte count, tumor necrosis factor-alpha, and histamine levels were determined before, during, and after cardiopulmonary bypass. Additionally, protein movement from the intravascular into the extravascular space during cardiopulmonary bypass was assessed by the measurement of plasma concentrations of proteins with molecular weights ranging from 21,200 to 718,000. Capillary leak syndrome developed in 13 of the 24 neonates. Patients with capillary leak syndrome, as compared with those without, had preoperatively higher C5a levels (C5a, 3.0 +/- 0.6 microgram/L vs 0.9 +/- 0.2 microgram/L) (mean +/- standard error of the mean) (p < 0.05) and higher leukocyte counts (leukocytes, 17.9 +/- 2.1 X 10(3) cells/ml versus 11.7 +/- 0.8 X 10(3) cells/ml) (p < 0.05), suggesting in these neonates a preoperative inflammatory state. Preoperative clinical and operative data were identical in both patient groups. Before cardiopulmonary bypass, serum protein concentrations were similar in all patients. Ten minutes after institution of cardiopulmonary bypass, protein concentrations fell to significantly lower values in patients with capillary leak syndrome than in those without: albumin (19% +/- 1.5% vs 30% +/- 6% of the prebypass value, p < 0.05), immunoglobulin G (17% +/- 1.5% vs 29% +/- 5.5%, p < 0.001), and alpha 2-macroglobulin (15% +/- 1.2% vs 25% +/- 4%, p < 0.02). During cardiopulmonary bypass, albumin concentrations remained significantly lower in patients with capillary leak syndrome than in those without, whereas hematocrit values were similar in both groups. During cardiopulmonary bypass, patients with capillary leak syndrome also had lower concentrations of complement proteins C3 and C4 but not C1 inhibitor. C3d/C3 ratio and C5a levels were similar in both patient groups. In contrast, histamine liberation during cardiopulmonary bypass was significantly more pronounced in patients with capillary leak syndrome than in those without (725.2 +/- 396.7 pg/ml vs -54.1 +/- 58.4 pg/ml, p < 0.05). Tumor necrosis factor-alpha levels after protamine administration were also significantly higher in patients with capillary leak syndrome (38.1 +/- 10.0 pg/ml vs 15.3 +/- 3.4 pg/ml, p < 0.05). Leukocyte count during and after cardiopulmonary bypass was similar in both patient groups. This study demonstrates increased protein leakage as early as 10 minutes after initiation of.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800157     DOI: 10.1016/s0022-5223(96)70053-3

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  27 in total

1.  Very early extubation after open-heart surgery in children does not influence cardiac function.

Authors:  U Meissner; J Scharf; J Dötsch; M Schroth
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

2.  Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.

Authors:  Evelyn Lechner; Anna Hofer; Rudolf Mair; Werner Moosbauer; Eva Sames-Dolzer; Gerald Tulzer
Journal:  Eur J Pediatr       Date:  2007-01-16       Impact factor: 3.183

3.  Factors prolonging length of stay in the cardiac intensive care unit following the arterial switch operation.

Authors:  Derek S Wheeler; Catherine L Dent; Peter B Manning; David P Nelson
Journal:  Cardiol Young       Date:  2007-12-20       Impact factor: 1.093

4.  Fresh frozen plasma prime and the level of gammaglobulin after pediatric cardiopulmonary bypass.

Authors:  Reza Shabanian; Alireza Dehestani; Minoo Dadkhah; Aliyeh Nikdoost; Parvin Akbari Asbagh; Hassan Radmehr; Mitra Rahimzadeh; Soroush Oveisi; Nima Rezaei; Manizheh Ahani; Mohammad Ali Navabi
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

5.  The Influence of Intraoperative Autotransfusion on Postoperative Hematocrit after Cardiac Surgery: A Cross-Sectional Study.

Authors:  Andrew J Stasko; Alfred H Stammers; Linda B Mongero; Eric A Tesdahl; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

6.  Changes in thyroid hormone concentrations during neonatal extracorporeal membrane oxygenation.

Authors:  L Leeuwen; A F J van Heijst; J van Rosmalen; Y B de Rijke; L W J E Beurskens; D Tibboel; E L T van den Akker; H IJsselstijn
Journal:  J Perinatol       Date:  2017-04-27       Impact factor: 2.521

Review 7.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

8.  Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.

Authors:  Kenneth E Mah; Shiying Hao; Scott M Sutherland; David M Kwiatkowski; David M Axelrod; Christopher S Almond; Catherine D Krawczeski; Andrew Y Shin
Journal:  Pediatr Nephrol       Date:  2017-11-11       Impact factor: 3.714

9.  Early outcomes after extracardiac conduit Fontan operation without cardiopulmonary bypass.

Authors:  Amy N McCammond; Kevin Kuo; Victoria N Parikh; Kameelah Abdullah; Raymond Balise; Frank L Hanley; Stephen J Roth
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

10.  Hemoglobin drift after cardiac surgery.

Authors:  Timothy J George; Claude A Beaty; Arman Kilic; Kara A Haggerty; Steven M Frank; William J Savage; Glenn J Whitman
Journal:  Ann Thorac Surg       Date:  2012-05-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.